Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Impact Biomedical Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 17 | 20 | +3 |
| Shares | 385.8K | 508.0K | +122.2K (+31.7%) |
| Value | $335.4K | $328.2K | −$7.16K (−2.1%) |
New holders (5)
Institutions that held Impact Biomedical Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 30,824 | $19.9K | 0.00% |
| Two Sigma Investments, LP | 22,700 | $14.7K | 0.00% |
| StoneX Group Inc. | 10,794 | $6.99K | 0.00% |
| Citigroup Inc | 8,784 | $5.68K | 0.00% |
| FMR LLC | 36 | $23 | 0.00% |
Sold out (2)
Institutions that held Impact Biomedical Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 60,315 | $52.5K |
| Morgan Stanley | 7,800 | $6.79K |